Skip to main content

Advertisement

Table 1 Clinical and biochemical data of the studied groups

From: Adiponectin: an adipocyte-derived hormone, and its gene encoding in children with chronic kidney disease

  CT MHD Controls
  (n = 32) (n = 46) (n = 70)
Age 9.14 ± 7.59 10.62 ± 3.49 10.7 ± 4.51
Gender (M/F) 15 (46.88%) /17(53.12%) 25(54.35%) /21(45.65%) 40(57.14%) /30(42.86%)
BMI(kg/m2) 17.64 ± 1.17 18.89 ± 3.00 20.88 ± 1.50
SBP (mmHg) 98.66 ± 6.66 127.13 ± 18.37 b* 94.55 ± 9.80
DBP (mmHg) 64.66 ± 6.67 85.15 ± 13.76 b* 60.59 ± 10.11
Creatinine (mg/dl) 3.93 ± 3.75 a* 6.32 ± 1.55 b* 0.77 ± 0.34
Predialysis urea, (mg/dl) 51.12 ± 10.45 a* 71.56 ± 20.61 b* 7.80 ± 2.64
eGFR, ml_min_1 _1.73m2 15.41 ± 1.76 a** 11.30 ± 3.35 b** 87 ± 8.9
Dialysis, Yrs   2.75 ± 1.59  
Nephropathies:    
Hereditary nephropathies 0 17  
renal hypoplasia or dysplasia 14 2  
obstructive uropathies 8 6  
neurogenic bladder 4 2  
Glomerulopathy 0 2  
Unknown 4 17  
Metabolic 2 0  
Antihypertensive drugs:    
α-adrenoceptor antagonists 2 2  
ß-blockers 0 9  
ACE inhibitors 6 17  
Ca channel blockers 10 29  
Kt/V   1.69 ± 0.42  
Total cholesterol (mg/dl) 164.44 ± 50.10 193.04 ± 51.37 b* 160.31 ± 18.74
Triglycerides (mg/dl) 160.78 ± 57.33 a** 147.00 ± 66.98 b** 65.31 ± 18.35
HDL cholesterol (mg/dl) 21.35 ± 1.17a* 27.34 ± 9.88 b* 39.55 ± 7.94
hs-CRP, mg/dl 3.04 ± 3.24 3.62 ± 3.97 b* 1.36 ± 0.67
IL6(pg/ml) 59.50 ± 46.48 a* 19.10 ± 23.68 b** 3.17 ± 1.56
Adiponectin (μg/ml) 154.00 ± 7.18 a** 52.44 ± 19.1 b** 24.80 ± 8.23
  1. Data was evaluated by ANOVA test. Values are presented as means ± SD or percentage as applicable. CT conservative treatment, MHD maintenance hemodialysis, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, ACE angiotensin converting enzyme, Kt/V adequacy of hemodialysis, hs-CRP high sensitivity c-reactive protein. a*P < 0.05 or a**P < 0.01vs. control and MHD b*P < 0.05 or b**P < 0.01 vs. control and CT .